close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.12 -0.99 (-2.53%)
Streaming Delayed Price Updated: 10:38 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 749,035
Open 38.07
Bid (Size) 38.08 (200)
Ask (Size) 38.12 (200)
Prev. Close 39.11
Today's Range 37.56 - 38.75
52wk Range 18.92 - 56.25
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗
Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven asset allocation. 
Via Benzinga
News headline image
Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗
Canaccord said Viking’s obesity pipeline is worth far more than the current valuation. 
Via Stocktwits

Performance

YTD
-7.3%
-7.3%
1 Month
+13.7%
+13.7%
3 Month
-9.4%
-9.4%
6 Month
+38.6%
+38.6%
1 Year
-22.4%
-22.4%

More News

Read More
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗
Via Stocktwits
News headline image
AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today ↗
Via Benzinga
Topics Stocks
Eli Lilly, Novo Nordisk Or A Dark Horse: Which Obesity-Drug Stock Are Retail Traders Most Bullish On Over Next 5 Years? ↗
Via Stocktwits
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera ↗
Via Stocktwits
News headline image
2 Monster Stocks in the Making ↗
Via The Motley Fool
News headline image
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗
Via Stocktwits
News headline image
Is There a Future for Viking Therapeutics? ↗
Via The Motley Fool
News headline image
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. ↗
Via Investor's Business Daily
Topics Government
News headline image
Druckenmiller's Viking Trade Just Hit A Golden Cross — And A Sweet 36% Gain ↗
Via Benzinga
News headline image
Jim Cramer Says 'Take A Pass' On This Tech Stock, Won't Go Near Oils ↗
Via Benzinga
News headline image
Here's Why Shares in Viking Therapeutics Shot Higher in October ↗
Via The Motley Fool
News headline image
Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets. ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Prediction: The Next Eli Lilly Might Already Be Trading Under $50 ↗
Via The Motley Fool
News headline image
Should You Buy Viking Therapeutics Before Nov. 5? ↗
Via The Motley Fool
News headline image
3 Promising Growth Stocks That Are Down Around 60% From Their Highs ↗
Via The Motley Fool
News headline image
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise ↗
Via Stocktwits
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Viking Therapeutics: High Risk, High Reward Play ↗
Via MarketBeat
News headline image
Here's Why This Obesity Drug Company's Share Price Soared Today ↗
Via The Motley Fool
Topics Earnings
News headline image
Why Is Viking Therapeutics Stock Rising Today? ↗
Via Benzinga
News headline image
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies ↗
Via Investor's Business Daily
News headline image
Viking Therapeutics (NASDAQ:VKTX) Reports Q3 2025 Earnings Miss and 2.8% After-Hours Decline ↗
Via Chartmill
Topics Earnings

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 38.12
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 11/17/25 10:38 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.80B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today